MEDICAL CITY DALLAS — History
CCN 450647 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$1.3B
Latest Revenue (FY2022)
+8.6%
Revenue CAGR (3yr)
49.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.1B | $1.3B | $1.3B | +4.3% | +8.6% |
| Operating Expenses | $666M | $727M | $667M | -8.2% | +0.1% |
| Operating Margin | 40.7% | 42.8% | 49.7% | +16.0% | +10.5% |
| Net Income | $457M | $544M | $658M | +21.0% | +20.1% |
| Licensed Beds | 819 | 819 | 819 | +0.0% | +0.0% |
| Total Patient Days | 192,109 | 200,630 | 208,040 | +3.7% | +4.1% |
| Medicare Day % | 18% | 15% | 15% | -2.2% | -10.3% |
| Medicaid Day % | 3% | 3% | 2% | -17.8% | -11.1% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +18.0% ($1.1B → $1.3B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.6%
This Hospital
+7.6%
State Avg
Latest Margin
49.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.4B | 54.2% |
| FY2024 (proj) | $1.5B | 58.7% |
| FY2025 (proj) | $1.6B | 63.2% |